Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

QNRX — Quoin Pharmaceuticals, Ltd. Dilution Risk Tracker

Track QNRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track QNRX — Get alerts when the score changes →

As of August 28, 2026, Quoin Pharmaceuticals, Ltd. (QNRX) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Quoin Pharmaceuticals, Ltd. has a market capitalization of $10.16M, 70.29M shares outstanding, 21 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for QNRX.
🔔 Track QNRX — Get forecast alerts →

Market Data

Market Cap$10.16M
Shares Outstanding70.29M
FloatN/A
Cash$10.80M
Debt$2.17M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 40.6% shares (2026Q1 vs prior)
21 institutional holders · 1.27M shares
#1 Ikarian Capital, LLC 211.5K shares
#2 Dauntless Investment Group, LLC 196.6K shares
#3 Woodline Partners LP 159.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest115.8K
Days to Cover10.7
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-10-14
xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-02-06
4 INSIDER TRANSACTION 2026-02-06
Full SEC filing analysis available with free account

Recent News

No recent news

Factual QNRX Dilution Snapshot

Quoin Pharmaceuticals, Ltd. (QNRX) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track QNRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note